|
|
|
|
||
Sorrento Receives US FDA Clearance to Proceed With Phase 1 Clinical Trial of STI-1499 (COVI-GUARD) Neutralizing Antibody in COVID-19 Positive Patients Sorrento Receives US FDA Clearance to Proceed With Phase 1 Clinical Trial of STI-1499 (COVI-GUARD) Neutralizing Antibody in COVID-19 Positive Patients Full press release: https://investors.sorrentotherapeutics.com/news-releases/news-release-details/sorrento-receives-us-fda-clearance-proceed-phase-1-clinical |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
550 | Re: Sorrento Receives US FDA Clearance to Proceed With Phase 1 Clinical Trial of STI-1499 (COVI-GUARD) Neutralizing Antibody in COVID-19 Positive Patients | grepgrep | 3 | 9/17/2020 2:30:39 AM |
551 | Re: Sorrento Receives US FDA Clearance to Proceed With Phase 1 Clinical Trial of STI-1499 (COVI-GUARD) Neutralizing Antibody in COVID-19 Positive Patients | grepgrep | 5 | 9/17/2020 2:35:27 AM |